Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Randomized Clinical Trials can be Accurately Classified in terms of their Methodological Validity by their Representations and Cochrane Reviewers’ Comments (Preprint)
0
Zitationen
3
Autoren
2023
Jahr
Abstract
<sec> <title>BACKGROUND</title> Evidence-based medicine requires evaluating and critically appraising documents. The process needs (semi)automated methods to distinguish valid from invalid randomized clinical trials (RCTs). </sec> <sec> <title>OBJECTIVE</title> The present study aimed to test the potential of RCT representations, Cochrane reviewers’ comments, and comment-expanded representations to learn a machine to classify RCTs into different validity categories. </sec> <sec> <title>METHODS</title> To build a test collection, 9,063 RCTs referred to by 132 open-access systematic reviews in the Cochrane database were identified, being tagged as “included” and having PMID. The RCTs’ methodological validity scores were extracted from the Cochrane database and their representative features (i.e., titles, abstracts, and author keywords) from PubMed. To classify the RCTs based on their (in)validity, machine learning was conducted using the kNN algorithm, with 10-fold cross-validation, in the KNIME Data Mining Platform. </sec> <sec> <title>RESULTS</title> The results showed that the comments and representations can accurately classify RCTs. The classification accuracy values for the comments ranged from 0.758 (for incomplete outcome data) to 0.896 (for potential threats to validity). The accuracy values for the RCT representations ranged from 0.691 (for random sequence generation) to 0.757 (for selective outcome reporting). After expanding the representations by the comments, improvements were observed in the accuracy values, ranging from 0.105 (for blinding of participants, personnel, and outcome assessors) to 0.196 (for random sequence generation). </sec> <sec> <title>CONCLUSIONS</title> The RCTs’ representations and Cochrane reviewers’ comments showed effectiveness in classifying them in their validity categories, with the latter being even more powerful. The comments also enriched the representations and improved their classification accuracy. </sec>
Ähnliche Arbeiten
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
2021 · 87.395 Zit.
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 · 82.932 Zit.
The Measurement of Observer Agreement for Categorical Data
1977 · 77.384 Zit.
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 · 63.130 Zit.
Measuring inconsistency in meta-analyses
2003 · 61.808 Zit.